Here is a data-driven look at Credit Analysis and Research (CARERATING), covering financial performance, valuation, and shareholding trends.
Care Rating Revenue Trend
Credit Analysis and Research clocked ₹280 Cr in revenue for FY2021, up 14.8% from FY2020.
Revenue compounded at 5.0% annually over 9 years for Credit Analysis and Research. It's a reasonable growth rate that's roughly kept pace with the broader market.
Credit Analysis and Research's ₹280 Cr revenue base puts it in the smaller bracket among rating agencies companies in India.
| Year | Revenue | YoY % |
|---|---|---|
| FY2021 | ₹280 Cr | +14.8% |
| FY2020 | ₹244 Cr | -23.6% |
| FY2019 | ₹319 Cr | -4.1% |
| FY2018 | ₹333 Cr | +15.7% |
| FY2017 | ₹287 Cr | — |
View Credit Analysis and Research's full 10-year revenue trend with CAGR analysis →
Is Care Rating Undervalued
Per the P/E Ratio model, Credit Analysis and Research has an estimated intrinsic value of ₹961 (40.8% downside).
Credit Analysis and Research shares are currently trading at ₹1,622.60.
Craytheon also calculates intrinsic value using the EPS Growth and DCF models. The full breakdown with assumptions is available in the detailed analysis.
| Model | Est. Fair Value | vs. Current Price |
|---|---|---|
| P/E Ratio | ₹961 | 40.8% downside to fair value |
| EPS Growth | Upgrade | Upgrade |
| DCF | Upgrade | Upgrade |
See all valuation models for Credit Analysis and Research with detailed assumptions →
Care Rating Shareholding Pattern
Credit Analysis and Research is a widely held company with no promoter group. Ownership is distributed across institutional and public shareholders.
FII ownership stands at 23.2%, down from the 24.6% recorded a year ago.
On the domestic institutional side, the holding is 31.4% as of March 2026 — up from 29.8%.
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Mar 2026 | 0.0% | 23.2% | 31.4% | 45.4% |
| Dec 2025 | 0.0% | 23.0% | 31.3% | 45.7% |
| Sep 2025 | 0.0% | 23.6% | 31.6% | 44.8% |
| Jun 2025 | 0.0% | 24.6% | 29.8% | 45.6% |
Track quarterly shareholding changes for Credit Analysis and Research →
Care Rating Balance Sheet
Proportional view as of 3 Jun 2026. Hover blocks for details.
Assets
Liabilities & Equity
FY2021 total assets: ₹6.72B (up 8.5% YoY from ₹6.19B).
Top categories: Cash & ST Investments (72.6%), Property, Plant & Equipment (10.5%), Other Assets (7.0%).
Of the ₹6.72B in liabilities and equity, 88.3% is shareholder equity, 0.0% is interest-bearing debt, and 11.7% is operating liabilities. Notable shift: Other Liabilities is down 33.1% YoY (₹825.14M → ₹551.97M).
Balance sheet composition — FY 2021
| Category | Value |
|---|---|
| Cash & ST Investments | 4.88B |
| Receivables | 213.56M |
| Property, Plant & Equipment | 702.12M |
| Investments | 343.96M |
| Intangibles & Goodwill | 114.32M |
| Other Assets | 467.73M |
| Category | Value |
|---|---|
| Equity | 5.93B |
| Trade Payables | 235.36M |
| Other Liabilities | 551.97M |
Care Rating Key Takeaways
Bringing the key threads together for Credit Analysis and Research (CARERATING) as a rating agencies investment opportunity.
Revenue of ₹280 Cr in FY2021, up 14.8% year-over-year.
Long-term revenue has been compounding at 5.0% annually over 9 years.
The P/E Ratio model implies 40.8% downside to fair value from the current price. The remaining two models are worth cross-checking before drawing a conclusion — sign up to see the full analysis.
Unlock Full Analysis
For the complete 10-year financial history with interactive charts and growth analysis, explore Credit Analysis and Research's detailed profile on Craytheon.